Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies

2009 ◽  
Vol 100 (4) ◽  
pp. 317-320 ◽  
Author(s):  
Pompiliu Piso ◽  
Gabriel Glockzin ◽  
Phillipp von Breitenbuch ◽  
Felix Cristoph Popp ◽  
Marc Hendrik Dahlke ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Intraperitoneal Chemotherapy ◽  
Cytoreductive Surgery ◽  
Hyperthermic Intraperitoneal Chemotherapy ◽  
Peritoneal Surface ◽  
Peritoneal Surface Malignancies

scholarly journals Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?

2017 ◽  
Vol 30 (4) ◽  
pp. 203-206
Author(s):  
Malgorzata Skierucha ◽  
Karol Polom ◽  
Karol Rawicz-Pruszynski ◽  
Jerzy Mielko ◽  
Robert Sitarz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Gastric Cancer ◽  
Intraperitoneal Chemotherapy ◽  
Cytoreductive Surgery ◽  
Hyperthermic Intraperitoneal Chemotherapy ◽  
Metastatic Gastric Cancer ◽  
Peritoneal Surface ◽  
Number Of Patients ◽  
Peritoneal Surface Malignancies

Abstract Introduction. So far there are no reports devoted exclusively to the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in metastatic gastric cancer. Current literature concerning this issue was, thus, reviewed in order to: 1) search for such data concerning metastatic gastric cancer; 2) assess if the latest reviews evenly pertain to all peritoneal surface malignancies; and 3) conclude if they are a reliable source of data for patients with metastatic gastric cancer. Materials and Methods. The electronic PubMed/MEDLINE and EMBASE databases were retrieved for studies concerning the influence of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on quality of life in patients with metastatic gastric cancer and regardless of initial diagnosis. The data on the number of patients with particular tumours were analysed and the results were presented in the form of a table. Results. Approximately half of all patients encompassed by the reviews had a form of primary peritoneal surface malignancies. Within peritoneal metastases, the most numerous were colorectal (21-24%) and ovarian cancers (5-15%). Gastric cancers and sarcomas were the smallest defined subgroups (4% each). Conclusions. The promising outcomes in quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in primary peritoneal surface malignancies might differ from rarely reported ones in metastatic gastric cancer. The problem needs further, gastric cancer-devoted investigations.

scholarly journals Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes

Cancers ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2387
Author(s):  
Jerzy Mielko ◽  
Karol Rawicz-Pruszyński ◽  
Katarzyna Sędłak ◽  
Katarzyna Gęca ◽  
Magdalena Kwietniewska ◽  
...  
Keyword(s):  
Learning Curve ◽  
Intraperitoneal Chemotherapy ◽  
Cytoreductive Surgery ◽  
Hyperthermic Intraperitoneal Chemotherapy ◽  
Oncological Outcomes ◽  
Peritoneal Surface ◽  
Peritoneal Surface Malignancies

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a complex, highly specialized procedure used to treat peritoneal surface malignancies (PSM) [...]

Sign in / Sign up

Export Citation Format

Share Document